NSI-189 Phosphate: A Neurogenic Compound for Depression and Cognitive Enhancement

Exploring the therapeutic potential of a novel neurogenic compound for treating depression and improving cognitive function.

Get a Quote & Sample

Key Advantages

Novel Mechanism

Unlike traditional antidepressants, NSI-189 phosphate operates via a neurogenic pathway, potentially offering a new approach to treating depression and related cognitive impairments.

Cognitive Improvement

Research suggests that NSI-189 phosphate can lead to significant enhancements in cognitive functions, such as memory and executive function, which are often compromised in patients with MDD.

Favorable Tolerability

Clinical trials indicate that NSI-189 phosphate is generally well-tolerated across various doses, with a good safety profile and minimal serious adverse effects.

Key Applications

Depression Treatment

NSI-189 Phosphate is being studied as a primary treatment for Major Depressive Disorder, aiming to alleviate mood symptoms through its neurogenic properties.

Cognitive Enhancement

The compound shows promise in improving cognitive functions such as memory and executive functioning, addressing a common challenge in depression management.

Neurogenesis Stimulation

By directly stimulating the generation of new neurons in the hippocampus, NSI-189 Phosphate aims to reverse the neural atrophy associated with depression.

Research in CNS Disorders

Beyond depression, NSI-189 Phosphate is explored for its potential in other central nervous system disorders, highlighting its versatile neurotrophic effects.